Dr. Carmen is a consultant with Pullan Consulting. She works with companies across all biotechnology sectors, with an emphasis on cell and gene therapy, helping them shape and execute business strategies. In her previous roles she was responsible for out-licensing an enabling technology for cellular engineering at MaxCyte. Before that, she was responsible for establishing partnerships with developers of cell-based medicines in order to expand the cell therapy contract manufacturing business at Lonza. Dr Carmen has been instrumental in the establishment of the Standards Coordinating Body for Regenerative Medicines and is a member of the Board of Directors. She is an active member of the Science and Technology Committee of the Alliance for Regenerative Medicine and has served on the Commercialization Committee for the International Society of Cellular Therapy. Dr Carmen earned a Doctorate from the Johns Hopkins University School of Public Health and a Bachelor of Science from the University of Florida.
A little more about Jessica...
In June of 2015 Jessica swam across the Chesapeake Bay (4.4 Miles)